BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 33585219)

  • 1. Development of an Immune-Related Gene Signature for Prognosis in Melanoma.
    Zhang JA; Zhou XY; Huang D; Luan C; Gu H; Ju M; Chen K
    Front Oncol; 2020; 10():602555. PubMed ID: 33585219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of Tumor Mutation Burden in Immune Infiltration and Prognosis in Cutaneous Melanoma.
    Kang K; Xie F; Mao J; Bai Y; Wang X
    Front Oncol; 2020; 10():573141. PubMed ID: 33072607
    [No Abstract]   [Full Text] [Related]  

  • 3. Immune-related prognostic genes signatures in the tumor microenvironment of sarcoma.
    Wang J; Gong M; Xiong Z; Zhao Y; Xing D
    Math Biosci Eng; 2021 Mar; 18(3):2243-2257. PubMed ID: 33892543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-omics analysis of tumor mutation burden combined with immune infiltrates in melanoma.
    Jiang F; Wu C; Wang M; Wei K; Zhou G; Wang J
    Clin Chim Acta; 2020 Dec; 511():306-318. PubMed ID: 33164879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and validation of a novel immune-related signature associated with macrophages and CD8 T cell infiltration predicting overall survival for hepatocellular carcinoma.
    Huo J; Wu L; Zang Y
    BMC Med Genomics; 2021 Sep; 14(1):232. PubMed ID: 34544391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 9-Gene Signature Correlated With CD8
    Yan K; Lu Y; Yan Z; Wang Y
    Front Immunol; 2021; 12():622563. PubMed ID: 34220795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and Validation of a Tumor Mutation Burden-Related Immune Prognostic Model for Lower-Grade Glioma.
    Yin W; Jiang X; Tan J; Xin Z; Zhou Q; Zhan C; Fu X; Wu Z; Guo Y; Jiang Z; Ren C; Tang G
    Front Oncol; 2020; 10():1409. PubMed ID: 32974146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and Verification of Immune-Related Gene Prognostic Signature Based on ssGSEA for Osteosarcoma.
    Xiao B; Liu L; Li A; Xiang C; Wang P; Li H; Xiao T
    Front Oncol; 2020; 10():607622. PubMed ID: 33384961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune and Stroma Related Genes in Breast Cancer: A Comprehensive Analysis of Tumor Microenvironment Based on the Cancer Genome Atlas (TCGA) Database.
    Xu M; Li Y; Li W; Zhao Q; Zhang Q; Le K; Huang Z; Yi P
    Front Med (Lausanne); 2020; 7():64. PubMed ID: 32195260
    [No Abstract]   [Full Text] [Related]  

  • 10. Increased expression of POLR3G predicts poor prognosis in transitional cell carcinoma.
    Liu X; Zhang W; Wang H; Lai CH; Xu K; Hu H
    PeerJ; 2020; 8():e10281. PubMed ID: 33194434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune-Stromal Score Signature: Novel Prognostic Tool of the Tumor Microenvironment in Lung Adenocarcinoma.
    Qi X; Qi C; Qin B; Kang X; Hu Y; Han W
    Front Oncol; 2020; 10():541330. PubMed ID: 33072571
    [No Abstract]   [Full Text] [Related]  

  • 12. Prognostic value of tumor immune cell infiltration patterns in colon adenocarcinoma based on systematic bioinformatics analysis.
    Xu H; Xu Q; Yin L
    Cancer Cell Int; 2021 Jul; 21(1):344. PubMed ID: 34217290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting the clinical outcome of melanoma using an immune-related gene pairs signature.
    Meng L; He X; Zhang X; Zhang X; Wei Y; Wu B; Li W; Li J; Xiao Y
    PLoS One; 2020; 15(10):e0240331. PubMed ID: 33031392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Immune-Related Prognostic Signature Predicts Overall Survival in Stomach Adenocarcinomas.
    Zhou K; Hu N; Hong Y; Wu X; Zhang J; Lai H; Zhang Y; Wu F
    Front Genet; 2022; 13():903393. PubMed ID: 35677557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishing a Prognostic Model Based on Ulceration and Immune Related Genes in Melanoma Patients and Identification of EIF3B as a Therapeutic Target.
    Wu Z; Lei K; Xu S; He J; Shi E
    Front Immunol; 2022; 13():824946. PubMed ID: 35273605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of CXCL13 and Immune Cell Infiltration Signature in Clear Cell Renal Cell Carcinoma.
    Jiao F; Sun H; Yang Q; Sun H; Wang Z; Liu M; Chen J
    Int J Med Sci; 2020; 17(11):1610-1624. PubMed ID: 32669964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hierarchical Clustering of Cutaneous Melanoma Based on Immunogenomic Profiling.
    Yu J; Xie M; Ge S; Chai P; Zhou Y; Ruan J
    Front Oncol; 2020; 10():580029. PubMed ID: 33330057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An immune-related gene signature for determining Ewing sarcoma prognosis based on machine learning.
    Ren EH; Deng YJ; Yuan WH; Wu ZL; Zhang GZ; Xie QQ
    J Cancer Res Clin Oncol; 2021 Jan; 147(1):153-165. PubMed ID: 32968877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of recurrence marker associated with immune infiltration in prostate cancer with radical resection and build prognostic nomogram.
    Rui X; Shao S; Wang L; Leng J
    BMC Cancer; 2019 Dec; 19(1):1179. PubMed ID: 31795990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of an immune-related signature for the prognosis of uveal melanoma.
    Li YZ; Huang Y; Deng XY; Tu CS
    Int J Ophthalmol; 2020; 13(3):458-465. PubMed ID: 32309184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.